Expression of angiogenic factors in hepatocellular carcinoma after transcatheter arterial chemoembolization

被引:0
|
作者
Liao Xiaofeng
Yi Jilin
Li Xingrui
Yang Zhifang
Deng Wei
Tian Geng
机构
[1] Huazhong University of Science and Technology,Department of General Surgery, Tongji Hospital, Tongji Medical College
关键词
hepatocellular carcinoma; chemoembolization; vascular endothelial growth factor; basic fibroblast growth factor;
D O I
10.1007/BF02829514
中图分类号
学科分类号
摘要
In order to investigate the changes of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) expression in residual hepatocellular carcinoma (HCC) after transcatheter arterial chemoembolization (TACE), the expression levels of VEGF and bFGF expression in specimens surgically removed from 48 HCC patients were detected by immunohistochemical methods, and staining intensity of VEGF and bFGF was assessed by a computer-assisted image-analyzer. Among the 48 patients, 25 underwent partial hepatectomy alone (single operating group), and 23 were subjected to second stage surgical resection after TACE (TACE group). The results showed that the average absorbance value (A) of VEGF was higher in TACE group than that in single operating group (0.152±0.021 vs 0.131±0.012,P<0.01). The Average A of bFGF in TACE group was 0.127±0.023, higher than in single operating group (0.111±0.016,P<0.05). These results suggested that TACE of HCC can up-regulate the expression of VEGF and bFGF in HCC tissues possibly due to anoxia and ischemia.
引用
收藏
页码:280 / 282
页数:2
相关论文
共 50 条
  • [31] Quality of life after radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma: comparison with transcatheter arterial chemoembolization alone
    Yan-Bin Wang
    Min-Hua Chen
    Kun Yan
    Wei Yang
    Ying Dai
    Shan-Shan Yin
    Quality of Life Research, 2007, 16 : 389 - 397
  • [32] TREATMENT OF HEPATOCELLULAR-CARCINOMA BY TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION AND ANALYSIS OF PROGNOSTIC FACTORS
    HSIEH, MY
    CHANG, WY
    WANG, LY
    CHEN, SC
    CHUANG, WL
    LU, SN
    WU, DK
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1992, 31 : S82 - S85
  • [33] CURRENT STATUS OF TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION FOR HEPATOCELLULAR CARCINOMA
    He, Qing
    Liu, Yang
    Yang, Ning-Ning
    Guan, Yong-Song
    ACTA MEDICA MEDITERRANEA, 2018, 34 (02): : 531 - 542
  • [34] Pulmonary complications of transcatheter arterial chemoembolization for hepatocellular carcinoma
    Quan M Nhu
    Harry Knowles
    Paul J Pockros
    Catherine T Frenette
    World Journal of Respirology, 2016, (03) : 69 - 75
  • [35] Hepatocellular carcinoma: Transcatheter arterial chemoembolization of the gonadal artery
    Kim, HC
    Chung, JW
    Jae, HJ
    Lee, W
    So, YH
    Park, JH
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2006, 17 (04) : 703 - 709
  • [36] Gemcitabine transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma
    Hammond, John S.
    Franko, Jan
    Holloway, Shane E.
    Heckman, Jason T.
    Orons, Phillip D.
    Gamblin, T. Clark
    HEPATO-GASTROENTEROLOGY, 2014, 61 (133) : 1339 - 1343
  • [37] TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION IN THE TREATMENT OF HEPATOCELLULAR-CARCINOMA
    FIGUERAS, J
    VALLS, C
    PAMIES, JJ
    BENASCO, C
    SANCHO, C
    RAFECAS, A
    DOMINGUEZ, J
    TORRAS, J
    FABREGAT, J
    BALIELLAS, C
    MONTANA, X
    JAURRIETA, EY
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 1993, 83 (01) : 21 - 25
  • [38] Thermoresponsive hydrogel for transcatheter arterial chemoembolization of hepatocellular carcinoma
    Zhao, Wei
    Xu, Jiabin
    You, Yuanyuan
    Guo, Zhenhu
    Xiang, Yun
    Hao, Kenan
    He, Xiaofeng
    Zhao, Peng
    CHEMICAL COMMUNICATIONS, 2023, 59 (61) : 9352 - 9355
  • [39] Risk factors for the leakage of chemotherapeutic agents into systemic circulation after transcatheter arterial chemoembolization of hepatocellular carcinoma
    Hsieh, Ming-Yen
    Lin, Zu-Yau
    Chen, Su-Hwei
    Chuang, Wan-Long
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2011, 27 (10): : 431 - 436
  • [40] INCIDENCE AND RISK FACTORS OF CONTRAST-INDUCED NEPHROPATHY AFTER TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION IN HEPATOCELLULAR CARCINOMA
    Aoe, Mari
    Kanemitsu, Takafumi
    Ohki, Takamasa
    Ambe, Hiroko
    Furukawa, Emi
    Kurata, Yu
    Ichikawa, Masahiro
    Ohara, Ken
    Honda, Tomoko
    Furuse, Satoshi
    Saito, Katsunori
    Toda, Nobuo
    Mise, Naobumi
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 408 - 409